[Wilson disease].
Shimizu
Norikazu
N
Second Department of Pediatrics, Toho University School of Medicine, Ohashi Hospital.
D000251:Adenosine Triphosphatases / Q000235:genetics; D017668:Age of Onset; D015415:Biomarkers / Q000032:analysis; D027682:Cation Transport Proteins / Q000235:genetics; D002570:Ceruloplasmin / Q000032:analysis; D002614:Chelating Agents / Q000627:therapeutic use; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics; D003300:Copper / Q000032:analysis; D000073840:Copper-Transporting ATPases; D003704:Dementia / Q000209:etiology; D003937:Diagnosis, Differential; D006527:Hepatolenticular Degeneration / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D016031:Liver Transplantation; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D010396:Penicillamine / Q000627:therapeutic use; D014266:Trientine / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D015415:Biomarkers; D027682:Cation Transport Proteins; D002614:Chelating Agents; D003300:Copper; D002570:Ceruloplasmin; D000251:Adenosine Triphosphatases; D000073840:Copper-Transporting ATPases; D010396:Penicillamine; D015032:Zinc; D014266:Trientine